1.63 USD
↘ 0.03 (1.81%)AT CLOSE (11:59 AM EDT)
Imunon, Inc. Common Stock
IMNNNASDAQ • USD
1.60
↘ 0.03 (1.72%)
POST MARKET (AS OF 07:55 PM EDT)
Post Market
AS OF 07:55 PM EDT
1.60
↘ 0.03 (1.72%)
Market: CLOSED
Imunon, Inc. Common Stock (IMNN) is currently trading at $1.60. The stock presents a bearish profile across the board: technical indicators signal "Strong Sell" and our fundamental models agree with a "Sell" rating. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.
Technical & fundamental data as of Aug 26, 2026.
Open?$1.62
High?$1.66
Low?$1.58
Prev. Close?$1.66
Volume?48.4K
Avg. Volume?199.3K
VWAP?$1.63
Rel. Volume?0.24x
Bid / Ask
Bid?$1.55 × 100
Ask?$1.65 × 1.0K
Spread?$0.10
Midpoint?$1.60
Valuation & Ratios
Market Cap?9.1M
Shares Out?5.6M
Float?4.0M
Float %?96.2%
P/E Ratio?N/A
P/B Ratio?2.18
EPS?-$2.63
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective and durable responses across a broad array of human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. The first modality, TheraPlas, is developed for the coding of proteins and cytokines in the treatment of solid tumors. The second modality, PlaCCine, is developed for the coding of viral antigens that can elicit an immunological response. The company's clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer.
Themes
Address
997 LENOX DRIVE
LAWRENCEVILLE, NJ 08648
Phone: (609) 896-9100
LAWRENCEVILLE, NJ 08648
Phone: (609) 896-9100
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?65
Short Sent.?74
Piotroski F-Score?0/9Weak
Altman Z-Score?-42.44Distress
Confidence?45%Low
Short InterestLow
Short % of Float?2.79%Low
Short Interest?113.0K
Days to Cover?2.5
Free Float4.0M
Avg Daily Volume44.7K
Settlement Date2026-08-14
Financial Health
Current Ratio?1.82Adequate
Quick Ratio?1.82Adequate
Cash Ratio?1.44Strong
Debt/Equity?1.68High
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?2.18CHEAP▾
Peers100
S&P70
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-0.6CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-351.7%WEAK▾
S&P3
ROA?-98.3%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-15181485
Enterprise Value?$9.3M
Fundamentals ratios updated end of day